How gKetoC alleviates intestinal inflammation
Through in vitro and in vivo models, researchers find a mechanism by which bacteria-generated fatty acids regulate immune responses.
List view / Grid view
Through in vitro and in vivo models, researchers find a mechanism by which bacteria-generated fatty acids regulate immune responses.
A specialised drug-loaded nanoparticle, which can cross the blood-brain barrier, shrunk both breast tumours and breast cancer cells.
Researchers showed that ESI1, or similar compounds, may help to slow or even reverse cognitive losses that can occur during aging.
Scientists have discovered that each rheumatoid arthritis patient possesses a unique and diverse set of ACPAs.
In this Q&A, Debiopharm’s Principal Scientist Dr Luke Piggott defines the critical requirement of biomarkers for identifying rare diseases. He illuminates how AI-enhanced approaches are accelerating the drug discovery process, particularly regarding clinical trial enrolment, and the breakthroughs he hopes to see in the future.
Researchers discovered that measuring the concentrations of IL-18 in an individual’s blood could estimate future risk of stroke.
Confounder control and quantitative profiling revealed misleading associations between microbial markers and colorectal cancer development.
As we move towards more generalised AI models, neural networks and natural language interfaces, we’re starting to see machine learning take the place of higher order reasoning and data analysis “sense making.” Traditional scientific inquiry has typically been about asking specific questions of a specific model system under specific conditions.…
Researchers discovered that smooth muscle cells can change into cancer-like cell types and worsen atherosclerosis.
Researchers have revealed that genetically enhanced expression of GSDMB causes a disturbed interferon-response.
The study’s findings explain the genetic differences in people’s blood pressure, which could lead to personalised medicine approaches.
Zymeworks’ Dr Paul Moore, Dr Raffaele Colombo and Dr Jamie Rich discuss how advancements in ADCs are redefining cancer treatment. They elucidate the innovative strategies that are being developed to improve drug stability and how personalised medicine approaches are optimising outcomes for individual cancer patients, offering new hope across several…
The mouse model provides a new understanding of the fundamental aspects of KSHV, which will enable drug and vaccine development.
Dr Laura Figulla is the CEO of mbiomics. Laura co-founded mbiomics which is dedicated to unlocking the true value of the microbiome by developing next-generation live biotherapeutics (LBPs). Throughout her career, Laura has combined her entrepreneurial spirit with her diverse academic background in business, economics, and medicine to build companies that…
The new organoids demonstrate a greater diversity of TECs in culture and are capable of maturing T cells.